Metraipolis › archive › dc_a730a7e60db9

Patient Participation in Monitoring Potential Adverse Drug Events — Europe PMC PMID:41238200

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41238200
DOI
10.1055/a-2641-0265
License (as archived)
solo-consultazione
Archived
2026-11-09T15:47:23.564Z
SHA-256 of the archived text
b1a0b19244c9224ed43ccf1fade4b079c4c811893cb4916d778c684c196fc58b
Stable URL of this page
https://metraipolis.com/documento/dc_a730a7e60db9

How to cite

Patient Participation in Monitoring Potential Adverse Drug Events — Europe PMC PMID:41238200 — Europe PMC (en), https://europepmc.org/article/MED/41238200 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a730a7e60db9 (Metraipolis archive dc_a730a7e60db9, sha256 b1a0b19244c9224ed43ccf1fade4b079c4c811893cb4916d778c684c196fc58b)
BibTeX
@misc{dca730a7e60db9,
  title = {Patient Participation in Monitoring Potential Adverse Drug Events — Europe PMC PMID:41238200},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41238200},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a730a7e60db9; sha256 b1a0b19244c9224ed43ccf1fade4b079c4c811893cb4916d778c684c196fc58b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41238200. Agents can read the archived copy with the MCP tool read_document.